Skip to main content
Erschienen in: European Radiology 10/2010

01.10.2010 | Experimental

Percutaneous isolated liver perfusion with occlusion balloons and a catheter-based stent-graft-like perfusion device: an experimental study in a porcine model

verfasst von: Geert Maleux, Diethard Monbaliu, Chris Verslype, Christophe Casteleyn, Marc Van De Velde, Pieter Cornillie, Yvonne Hoogeveen, Eric Van Cutsem

Erschienen in: European Radiology | Ausgabe 10/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate the feasibility and safety of a novel percutaneous isolated liver perfusion (PILP) system in a porcine model.

Methods

The PILP catheter set, consisting of a portal vein and hepatic artery occlusion balloon and an hourglass-shaped vena cava stent-graft, was tested in six Dutch Landrace pigs. A veno-venous bypass between the distal portal vein and the right femoral vein, and isolated perfusion between the proximal portal vein and the hepatic veins were also created. Leak rate was determined using radioactivity measurement in the systemic circulation. Perfusion was then performed without (n = 2) or with cytotoxic drugs (n = 4). At the end of the procedure, all devices were retrieved and angiographic evaluation was performed of the involved vessel segments.

Results

In all pigs it was possible to insert, accurately position and retrieve all components of the PILP catheter set without angiographic signs of vessel-wall damage. Leakage rates to the systemic circulation were less than 7% over the course of the perfusion.

Conclusion

In a porcine model, the PILP system can be safely and accurately positioned, and showed successful vascular isolation of the liver, with a leak rate to the systemic circulation of less than 7%.
Literatur
1.
Zurück zum Zitat Llovett JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, Rodés J, Bruix J, Barcelona Liver Cancer Group (2002) Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734–1739CrossRef Llovett JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Solà R, Rodés J, Bruix J, Barcelona Liver Cancer Group (2002) Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734–1739CrossRef
2.
Zurück zum Zitat Sato KT, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL, Nemcek AA Jr, Barakat O, Benson A 3rd, Mandal R, Talamonti M, Wong CY, Miller FH, Newman SB, Shaw JM, Thurston KG, Omary RA, Salem R (2008) Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres: safety, efficacy and survival. Radiology 247:507–515CrossRefPubMed Sato KT, Lewandowski RJ, Mulcahy MF, Atassi B, Ryu RK, Gates VL, Nemcek AA Jr, Barakat O, Benson A 3rd, Mandal R, Talamonti M, Wong CY, Miller FH, Newman SB, Shaw JM, Thurston KG, Omary RA, Salem R (2008) Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres: safety, efficacy and survival. Radiology 247:507–515CrossRefPubMed
3.
Zurück zum Zitat Grover A, Alexander HR (2004) The past decade of experience with isolated hepatic perfusion. Oncologist 9:653–664CrossRefPubMed Grover A, Alexander HR (2004) The past decade of experience with isolated hepatic perfusion. Oncologist 9:653–664CrossRefPubMed
4.
Zurück zum Zitat Rothbarth J, Tollenaar RA, van de Velde CJ (2006) Recent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors. Expert Rev Anticancer Ther 6:553–565CrossRefPubMed Rothbarth J, Tollenaar RA, van de Velde CJ (2006) Recent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors. Expert Rev Anticancer Ther 6:553–565CrossRefPubMed
5.
Zurück zum Zitat Libutti SK, Bartlett DL, Fraker DL, Alexander HR (2000) Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies. J Am Coll Surg 191:519–530CrossRefPubMed Libutti SK, Bartlett DL, Fraker DL, Alexander HR (2000) Technique and results of hyperthermic isolated hepatic perfusion with tumor necrosis factor and melphalan for the treatment of unresectable hepatic malignancies. J Am Coll Surg 191:519–530CrossRefPubMed
6.
Zurück zum Zitat Alexander HR, Bartlett DL, Libutti SK, Pingpank JF, Fraker DL, Royal R, Steinberg SM, Helsabeck CB, Beresneva TH (2009) Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal cancer. Ann Surg Oncol 16:1852–1859CrossRefPubMed Alexander HR, Bartlett DL, Libutti SK, Pingpank JF, Fraker DL, Royal R, Steinberg SM, Helsabeck CB, Beresneva TH (2009) Analysis of factors associated with outcome in patients undergoing isolated hepatic perfusion for unresectable liver metastases from colorectal cancer. Ann Surg Oncol 16:1852–1859CrossRefPubMed
7.
Zurück zum Zitat Noter SL, Rothbarth J, Pijl ME, Keunen JE, Hartgrink HH, Tijl FG, Kuppen PJ, van de Velde CJ, Tollenaar RA (2004) Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver. Melanoma Res 14:67–72CrossRefPubMed Noter SL, Rothbarth J, Pijl ME, Keunen JE, Hartgrink HH, Tijl FG, Kuppen PJ, van de Velde CJ, Tollenaar RA (2004) Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver. Melanoma Res 14:67–72CrossRefPubMed
8.
Zurück zum Zitat van Etten B, de Wilt JH, Brunstein F, Eggermont AM, Verhoef C (2009) Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases. Eur J Surg Oncol 35:539–545PubMed van Etten B, de Wilt JH, Brunstein F, Eggermont AM, Verhoef C (2009) Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases. Eur J Surg Oncol 35:539–545PubMed
9.
Zurück zum Zitat van Iersel LB, Hoekman EJ, Gelderblom H, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Hartgrink HH, Kuppen PJ, Nortier JW, Tollenaar RA, van de Velde CJ (2008) Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases. Ann Surg Oncol 15:1891–1898CrossRefPubMed van Iersel LB, Hoekman EJ, Gelderblom H, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Hartgrink HH, Kuppen PJ, Nortier JW, Tollenaar RA, van de Velde CJ (2008) Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases. Ann Surg Oncol 15:1891–1898CrossRefPubMed
10.
Zurück zum Zitat van Iersel LB, Gelderblom H, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Putter H, Hartgrink HH, Uppen PJ, Nortier JW, Tollenaar RA, van de Velde CJ (2008) Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients. Ann Oncol 19:1127–1134CrossRefPubMed van Iersel LB, Gelderblom H, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Putter H, Hartgrink HH, Uppen PJ, Nortier JW, Tollenaar RA, van de Velde CJ (2008) Isolated hepatic melphalan perfusion of colorectal liver metastases: outcome and prognostic factors in 154 patients. Ann Oncol 19:1127–1134CrossRefPubMed
11.
Zurück zum Zitat van Iersel LB, Verlaan MR, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Sparidans RW, Gelderblom H, Kuppen PJ, Tollenaar RA, van de Velde CJ (2007) Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacologic evaluation. Eur J Surg Oncol 33:874–881PubMed van Iersel LB, Verlaan MR, Vahrmeijer AL, van Persijn van Meerten EL, Tijl FG, Sparidans RW, Gelderblom H, Kuppen PJ, Tollenaar RA, van de Velde CJ (2007) Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacologic evaluation. Eur J Surg Oncol 33:874–881PubMed
12.
Zurück zum Zitat Alexander HR, Libutti SK, Pingpank JF, Bartlett DL, Helsabeck C, Beresneva T (2005) Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy. Ann Surg Oncol 12:138–144CrossRefPubMed Alexander HR, Libutti SK, Pingpank JF, Bartlett DL, Helsabeck C, Beresneva T (2005) Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy. Ann Surg Oncol 12:138–144CrossRefPubMed
13.
Zurück zum Zitat Vahrmeijer AL, van Dierendonck JH, Keizer HJ, Beijnen JH, Tollenaar RA, Pijl ME, Marinelli A, Kuppen PJ, van Bockel JH, Mulder GJ, van de Velde CJ (2000) Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer to the liver. Br J Cancer 82:1539–1546CrossRefPubMed Vahrmeijer AL, van Dierendonck JH, Keizer HJ, Beijnen JH, Tollenaar RA, Pijl ME, Marinelli A, Kuppen PJ, van Bockel JH, Mulder GJ, van de Velde CJ (2000) Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer to the liver. Br J Cancer 82:1539–1546CrossRefPubMed
14.
Zurück zum Zitat Rothbarth J, Pijl ME, Vahrmeijer AL, Hartgrink HH, Tijl FG, Kuppen PJ, Tollenaar RA, van de Velde CJ (2003) Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver. Br J Surg 90:1391–1397CrossRefPubMed Rothbarth J, Pijl ME, Vahrmeijer AL, Hartgrink HH, Tijl FG, Kuppen PJ, Tollenaar RA, van de Velde CJ (2003) Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver. Br J Surg 90:1391–1397CrossRefPubMed
15.
Zurück zum Zitat Zeh HJ III, Brown CK, Holtzman MP, Egorin MJ, Holleran JL, Potter DM, Bartlett DL (2009) A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer. Ann Surg Oncol 16:385–394CrossRefPubMed Zeh HJ III, Brown CK, Holtzman MP, Egorin MJ, Holleran JL, Potter DM, Bartlett DL (2009) A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer. Ann Surg Oncol 16:385–394CrossRefPubMed
16.
Zurück zum Zitat Pingpank JF, Libutti SK, Chang R, Wood BJ, Neeman Z, Kam AW, Figg WD, Zhai S, Beresneva T, Seidel GD, Alexander HR (2005) Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol 23:3465–3474CrossRefPubMed Pingpank JF, Libutti SK, Chang R, Wood BJ, Neeman Z, Kam AW, Figg WD, Zhai S, Beresneva T, Seidel GD, Alexander HR (2005) Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies. J Clin Oncol 23:3465–3474CrossRefPubMed
17.
Zurück zum Zitat van Etten B, Brunstein F, van Ijken MG, Marinelli AW, Verhoef C, van der Sijp JR, Guetens G, de Boeck G, de Bruijn EA, de Wilt JH, Eggermont AM (2004) Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I–II study. Ann Surg Oncol 11:598–605CrossRefPubMed van Etten B, Brunstein F, van Ijken MG, Marinelli AW, Verhoef C, van der Sijp JR, Guetens G, de Boeck G, de Bruijn EA, de Wilt JH, Eggermont AM (2004) Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I–II study. Ann Surg Oncol 11:598–605CrossRefPubMed
18.
Zurück zum Zitat Savier E, Azoulay D, Huguet E, Lokiec F, Gil-Delgado M, Bismuth H (2003) Percutaneous isolated hepatic perfusion for chemotherapy: a phase 1 study. Arch Surg 138:325–332CrossRefPubMed Savier E, Azoulay D, Huguet E, Lokiec F, Gil-Delgado M, Bismuth H (2003) Percutaneous isolated hepatic perfusion for chemotherapy: a phase 1 study. Arch Surg 138:325–332CrossRefPubMed
19.
Zurück zum Zitat Eggermont AM, van Ijken MG, van Etten B, van der Sijp JR, ten Hagen TL, Wiggers T, Oudkerk M, de Boeck G, de Bruijn EA (2000) Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: from laboratory to the clinic towards a percutaneous procedure. Hepatogastroenterology 47:776–781PubMed Eggermont AM, van Ijken MG, van Etten B, van der Sijp JR, ten Hagen TL, Wiggers T, Oudkerk M, de Boeck G, de Bruijn EA (2000) Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: from laboratory to the clinic towards a percutaneous procedure. Hepatogastroenterology 47:776–781PubMed
20.
Zurück zum Zitat van Ijken MG, de Bruijn EA, de Boeck G, ten Hagen TL, van der Sijp JR, Eggermont AM (1998) Isolated hypoxic hepatic perfusion with tumor necrosis factor-alfa, melphalan, and mitomycine C using balloon catheter techniques: a pharmacokinetic study in pigs. Ann Surg 228:763–770CrossRefPubMed van Ijken MG, de Bruijn EA, de Boeck G, ten Hagen TL, van der Sijp JR, Eggermont AM (1998) Isolated hypoxic hepatic perfusion with tumor necrosis factor-alfa, melphalan, and mitomycine C using balloon catheter techniques: a pharmacokinetic study in pigs. Ann Surg 228:763–770CrossRefPubMed
21.
Zurück zum Zitat Verhoef C, de Wilt JH, Brunstein F, Marinelli AW, van Etten B, Vermaas M, Guetens G, de Boeck G, de Bruijn EA, Eggermont AM (2008) Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases: a new simplified technique in isolated hepatic perfusion. Ann Surg Oncol 15:1367–1374CrossRefPubMed Verhoef C, de Wilt JH, Brunstein F, Marinelli AW, van Etten B, Vermaas M, Guetens G, de Boeck G, de Bruijn EA, Eggermont AM (2008) Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases: a new simplified technique in isolated hepatic perfusion. Ann Surg Oncol 15:1367–1374CrossRefPubMed
22.
Zurück zum Zitat Harnek J, Cwikiel W, Bergqvist L, Persson B, Stridbeck H (1996) Isolated liver perfusion using percutaneous methods: an experimental study in the pig. Cardiovasc Intervent Radiol 19:418–422CrossRefPubMed Harnek J, Cwikiel W, Bergqvist L, Persson B, Stridbeck H (1996) Isolated liver perfusion using percutaneous methods: an experimental study in the pig. Cardiovasc Intervent Radiol 19:418–422CrossRefPubMed
23.
Zurück zum Zitat Beheshti MV, Denny DF Jr, Glickman MG, Bodden W, March JC, Strair R, Ravikumar TS (1992) Percutaneous isolated liver perfusion for treatment of hepatic malignancy: preliminary report. J Vasc Intervent Radiol 3:453–458CrossRef Beheshti MV, Denny DF Jr, Glickman MG, Bodden W, March JC, Strair R, Ravikumar TS (1992) Percutaneous isolated liver perfusion for treatment of hepatic malignancy: preliminary report. J Vasc Intervent Radiol 3:453–458CrossRef
24.
Zurück zum Zitat Rothbarth J, Pijl ME, Tollenaar RA, Tijl F, Ivancev K, Mulders GJ, Kuppen PJ, van de Velde CJ, Schultze Kool LJ (2003) An experimental minimally invasive perfusion technique for the treatment of liver metastases. Eur J Surg Oncol 29:757–763CrossRefPubMed Rothbarth J, Pijl ME, Tollenaar RA, Tijl F, Ivancev K, Mulders GJ, Kuppen PJ, van de Velde CJ, Schultze Kool LJ (2003) An experimental minimally invasive perfusion technique for the treatment of liver metastases. Eur J Surg Oncol 29:757–763CrossRefPubMed
25.
Zurück zum Zitat Dondelinger RF, Ghysels MP, Brisbois D, Donkers E et al (1998) Relevant radiological anatomy of the pig as a training model in interventional radiology. Eur Radiol 8:1254–1273CrossRefPubMed Dondelinger RF, Ghysels MP, Brisbois D, Donkers E et al (1998) Relevant radiological anatomy of the pig as a training model in interventional radiology. Eur Radiol 8:1254–1273CrossRefPubMed
Metadaten
Titel
Percutaneous isolated liver perfusion with occlusion balloons and a catheter-based stent-graft-like perfusion device: an experimental study in a porcine model
verfasst von
Geert Maleux
Diethard Monbaliu
Chris Verslype
Christophe Casteleyn
Marc Van De Velde
Pieter Cornillie
Yvonne Hoogeveen
Eric Van Cutsem
Publikationsdatum
01.10.2010
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 10/2010
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-010-1816-5

Weitere Artikel der Ausgabe 10/2010

European Radiology 10/2010 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.